Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis.
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Elan provides update post restructuring announcement of Tysabri collaboration
Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
The epidemiology and pathophysiology of neurogenic bladder.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Complex assessment in progressive multiple sclerosis: a case report.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Medical marijuana in neurology.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
2014 multiple sclerosis therapeutic update.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.

Pages